| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Fey, M.F.
|
|
|
21 |
S5 |
p. v158-v161
|
artikel
|
| 2 |
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
|
Van Cutsem, E.
|
|
|
21 |
S5 |
p. v93-v97
|
artikel
|
| 3 |
Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Glynne-Jones, R.
|
|
|
21 |
S5 |
p. v87-v92
|
artikel
|
| 4 |
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Eckel, F.
|
|
|
21 |
S5 |
p. v65-v69
|
artikel
|
| 5 |
Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up
|
Bellmunt, J.
|
|
|
21 |
S5 |
p. v134-v136
|
artikel
|
| 6 |
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Hogendoorn, P.C.W.
|
|
|
21 |
S5 |
p. v204-v213
|
artikel
|
| 7 |
BRCA in breast cancer: ESMO Clinical Practice Guidelines
|
Balmaña, J.
|
|
|
21 |
S5 |
p. v20-v22
|
artikel
|
| 8 |
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Pentheroudakis, G.
|
|
|
21 |
S5 |
p. v266-v273
|
artikel
|
| 9 |
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Pavlidis, N.
|
|
|
21 |
S5 |
p. v228-v231
|
artikel
|
| 10 |
Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines
|
Bovelli, D.
|
|
|
21 |
S5 |
p. v277-v282
|
artikel
|
| 11 |
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Haie-Meder, C.
|
|
|
21 |
S5 |
p. v37-v40
|
artikel
|
| 12 |
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Eichhorst, B.
|
|
|
21 |
S5 |
p. v162-v164
|
artikel
|
| 13 |
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Baccarani, M.
|
|
|
21 |
S5 |
p. v165-v167
|
artikel
|
| 14 |
Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Tilly, H.
|
|
|
21 |
S5 |
p. v172-v174
|
artikel
|
| 15 |
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Crinò, L.
|
|
|
21 |
S5 |
p. v103-v115
|
artikel
|
| 16 |
Editorial Board
|
|
|
|
21 |
S5 |
p. i-ii
|
artikel
|
| 17 |
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Plataniotis, G.
|
|
|
21 |
S5 |
p. v41-v45
|
artikel
|
| 18 |
Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use
|
Schrijvers, D.
|
|
|
21 |
S5 |
p. v244-v247
|
artikel
|
| 19 |
ESMO Clinical Practice Guidelines: development, implementation and dissemination
|
Pavlidis, N.
|
|
|
21 |
S5 |
p. v7-v8
|
artikel
|
| 20 |
ESMO Guidelines Working Group Disclosures
|
|
|
|
21 |
S5 |
p. v283-v284
|
artikel
|
| 21 |
Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Stahl, M.
|
|
|
21 |
S5 |
p. v46-v49
|
artikel
|
| 22 |
Familial colorectal cancer risk: ESMO Clinical Practice Guidelines
|
Balmaña, J.
|
|
|
21 |
S5 |
p. v78-v81
|
artikel
|
| 23 |
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Okines, A.
|
|
|
21 |
S5 |
p. v50-v54
|
artikel
|
| 24 |
Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Zucca, E.
|
|
|
21 |
S5 |
p. v175-v176
|
artikel
|
| 25 |
Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Casali, P.G.
|
|
|
21 |
S5 |
p. v98-v102
|
artikel
|
| 26 |
Guidelines Working Group Members
|
|
|
|
21 |
S5 |
p. v
|
artikel
|
| 27 |
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
|
Roila, F.
|
|
|
21 |
S5 |
p. v232-v243
|
artikel
|
| 28 |
Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications
|
Crawford, J.
|
|
|
21 |
S5 |
p. v248-v251
|
artikel
|
| 29 |
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Jelic, S.
|
|
|
21 |
S5 |
p. v59-v64
|
artikel
|
| 30 |
High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Stupp, R.
|
|
|
21 |
S5 |
p. v190-v193
|
artikel
|
| 31 |
Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Engert, A.
|
|
|
21 |
S5 |
p. v168-v171
|
artikel
|
| 32 |
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Cardoso, F.
|
|
|
21 |
S5 |
p. v15-v19
|
artikel
|
| 33 |
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Stahel, R.A.
|
|
|
21 |
S5 |
p. v126-v128
|
artikel
|
| 34 |
Management of cancer pain: ESMO Clinical Practice Guidelines
|
Jost, L.
|
|
|
21 |
S5 |
p. v257-v260
|
artikel
|
| 35 |
Management of febrile neutropenia: ESMO Clinical Practice Guidelines
|
de Naurois, J.
|
|
|
21 |
S5 |
p. v252-v256
|
artikel
|
| 36 |
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines
|
Peterson, D.E.
|
|
|
21 |
S5 |
p. v261-v265
|
artikel
|
| 37 |
Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Dummer, R.
|
|
|
21 |
S5 |
p. v194-v197
|
artikel
|
| 38 |
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
D'Addario, G.
|
|
|
21 |
S5 |
p. v116-v119
|
artikel
|
| 39 |
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Harousseau, J.-L.
|
|
|
21 |
S5 |
p. v155-v157
|
artikel
|
| 40 |
Nasopharyngeal cancer: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Chan, A.T.C.
|
|
|
21 |
S5 |
p. v187-v189
|
artikel
|
| 41 |
Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Öberg, K.
|
|
|
21 |
S5 |
p. v220-v222
|
artikel
|
| 42 |
Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Öberg, K.
|
|
|
21 |
S5 |
p. v223-v227
|
artikel
|
| 43 |
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Colombo, N.
|
|
|
21 |
S5 |
p. v23-v30
|
artikel
|
| 44 |
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Dreyling, M.
|
|
|
21 |
S5 |
p. v181-v183
|
artikel
|
| 45 |
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Reed, N.
|
|
|
21 |
S5 |
p. v31-v36
|
artikel
|
| 46 |
Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Cascinu, S.
|
|
|
21 |
S5 |
p. v55-v58
|
artikel
|
| 47 |
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Aebi, S.
|
|
|
21 |
S5 |
p. v9-v14
|
artikel
|
| 48 |
Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up
|
Labianca, R.
|
|
|
21 |
S5 |
p. v70-v77
|
artikel
|
| 49 |
Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Willemze, R.
|
|
|
21 |
S5 |
p. v177-v180
|
artikel
|
| 50 |
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Horwich, A.
|
|
|
21 |
S5 |
p. v129-v133
|
artikel
|
| 51 |
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Glimelius, B.
|
|
|
21 |
S5 |
p. v82-v86
|
artikel
|
| 52 |
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Escudier, B.
|
|
|
21 |
S5 |
p. v137-v139
|
artikel
|
| 53 |
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Sørensen, M.
|
|
|
21 |
S5 |
p. v120-v125
|
artikel
|
| 54 |
Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Casali, P.G.
|
|
|
21 |
S5 |
p. v198-v203
|
artikel
|
| 55 |
Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Grégoire, V.
|
|
|
21 |
S5 |
p. v184-v186
|
artikel
|
| 56 |
Table of Contents
|
|
|
|
21 |
S5 |
p. iv
|
artikel
|
| 57 |
Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Schmoll, H.-J.
|
|
|
21 |
S5 |
p. v147-v154
|
artikel
|
| 58 |
Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Schmoll, H.-J.
|
|
|
21 |
S5 |
p. v140-v146
|
artikel
|
| 59 |
The ESMO Guidelines Working Group acknowledges and thanks the following people who have acted as reviewers for these ESMO Clinical Practice Guidelines.
|
|
|
|
21 |
S5 |
p. vi-vii
|
artikel
|
| 60 |
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Pacini, F.
|
|
|
21 |
S5 |
p. v214-v219
|
artikel
|
| 61 |
Title Page
|
|
|
|
21 |
S5 |
p. iii
|
artikel
|
| 62 |
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management
|
Mandalà, M.
|
|
|
21 |
S5 |
p. v274-v276
|
artikel
|
Tijdschrift beschrijving